The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...

The Food and Drug Administration has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a proponent of ...

Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...

PFE also trades at a noticeable discount to the benchmark S&P 500’s 21.3X forward earnings multiple and its Zacks industry average of 16.4X. At current levels, Pfizer’s annual dividend also ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

This suggests that while Pfizer is navigating broader industry and economic challenges, it may also be facing company-specific hurdles. Pfizer’s current strategy, focusing on research and ...

After the war, Pfizer continued to focus on industrial chemicals as much as medicines, producing the citric acid needed for the emerging soft drinks industry, fuelling brands like Coca Cola and Dr ...

For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...

Seigerman said that Pfizer’s struggles to recover from waning Covid sales and identify a new revenue driver in its pipeline points to challenges of a rapidly evolving biopharmaceutical industry.

Pfizer could soon launch a multi-billion dollar ... but for oncology research and development efforts across the entire industry.” One key point that O’Day stressed was that Flatiron’s ...

We hoped industry layoffs would relent in 2024 ... during its Q1 results presentation that the biotech and partner Pfizer are dropping two phase 3 trials from their estrogen receptor degrader ...